✦ LIBER ✦

A Physiologically Based Pharmacokinetic Analysis of Capecitabine, a Triple Prodrug of 5-FU, in Humans: The Mechanism for Tumor-Selective Accumulation of 5-FU

✍ Scribed by Yuko Tsukamoto; Yukio Kato; Masako Ura; Ikuo Horii; Hideo Ishitsuka; Hiroyuki Kusuhara; Yuichi Sugiyama

Book ID: 110295840
Publisher: Springer US
Year: 2001
Tongue: English
Weight: 372 KB
Volume: 18
Category: Article
ISSN: 0724-8741
DOI: 10.1023/a:1010939329562

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Investigation of 5-FU disposition after

Investigation of 5-FU disposition after oral administration of capecitabine, a triple-prodrug of 5-FU, using a physiologically based pharmacokinetic model in a human cancer xenograft model: comparison of the simulated 5-FU exposures in the tumour tissue between human and xenograft model

✍ Yuko Tsukamoto; Yukio Kato; Masako Ura; Ikuo Horii; Tohru Ishikawa; Hideo Ishits 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB 👁 2 views

## Abstract The nonlinear pharmacokinetics of capecitabine, a triple prodrug of 5‐FU preferentially activated in tumour tissues, was investigated in human cancer xenograft models. A physiologically based pharmacokinetic (PBPK) model integrating the activation process of capecitabine to 5‐FU and 5‐F

Clinical determinants of tumor response

Clinical determinants of tumor response in patients with 5-FU based treatment for metastatic colorectal cancer. Results of a multivariate analysis of 3825 patients

✍ Köhne, C.; Cunningham, D.; DiCostanzo, F.; Glimelius, B.; Aranda, E.; Scheithaue 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 170 KB

EC3 COST-MINIMIZATION ANALYSIS OF CAPECI

EC3 COST-MINIMIZATION ANALYSIS OF CAPECITABINE + OXALIPLATIN (XELOX) VS. INFUSIONAL 5-FU/LV + OXALIPLATIN (FOLFOX-6) AS FIRST-LINE TREATMENT FOR METASTATIC COLORECTAL CANCER (MCRC) IN THE FRENCH SETTING

✍ G Perrocheau; M Ducreux; M Hebbar; M Ychou; G Lledo; T Conroy; R Faroux; JY Doui 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB